Safety and efficacy of a generic fixed-dose combination of stavudine, lamivudine and nevirapine antiretroviral therapy between HIV-infected patients with baseline CD4 <50 versus CD4 ≥ 50 cells/mm(3)

BACKGROUND: Antiretroviral therapy (ART) with a generic fixed-dose combination (FDC) of stavudine (d4T)/lamivudine (3TC)/nevirapine (NVP) is widely used in developing countries. The clinical data of this FDC among very advanced HIV-infected patients is limited. METHODS: A retrospective cohort study...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Manosuthi, Weerawat, Chimsuntorn, Sukanya, Likanonsakul, Sirirat, Sungkanuparph, Somnuek
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2007
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC1828738/
https://ncbi.nlm.nih.gov/pubmed/17352834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1742-6405-4-6
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi